Nghĩa của từ pertussis vaccine bằng Tiếng Việt
Vacxin ho gà
Đặt câu có từ "pertussis vaccine"
1. 208 Pertussis vaccine (acellular, component, adsorbed) ..5.3-3407 Pertussis vaccine (acellular, co-purified, adsorbed) ...........
2. DTaP : Diphtheria , tetanus , and acellular pertussis vaccine
DTaP : Vắc-xin ngừa bạch hầu , uốn ván , và ho gà không tế bào
3. Thus, Acellular pertussis vaccine is reserved for the 4th and …
4. The lack of a monovalent acellular pertussis vaccine limits the choices.
5. Cautions for Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Contraindications
6. Currently, all jurisdictions in Canada fund administration of acellular pertussis vaccine to adolescents.
7. However , you should discuss the risks of the pertussis vaccine with your doctor .
Tuy nhiên , bạn nên thảo luận các rủi ro của vắc-xin ho gà với bác sĩ của mình .
8. Background NACI recommends the administration of a single dose of the adolescent/adult formulation of the acellular pertussis vaccine to pre-adolescents, adolescents, and adults who have not received a dose of acellular pertussis vaccine.
9. In the United States, an acellular pertussis vaccine was recently licensed for the primary infant immunization series.
10. Acellular pertussis vaccine (aP) with three or more antigens prevents around 85% of typical whooping cough cases in children
11. • Afebrile convulsions have not been shown to be caused by pertussis vaccine and are not a contraindication to immunization.
12. The first three doses of acellular pertussis vaccine are the most critical in reducing infant mortality and hospitalization rates.
13. BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) is a noninfectious, sterile, vaccine for intramuscular administration
14. with acellular pertussis vaccine. As of September 2004, all provinces/territories had implemented universal adolescent acellular pertussis programs with Tdap.
15. Acellular (chemically detoxified or recombinant) pertussis vaccine formulation appears to cause fewer adverse reactions than whole-cell vaccine in most studies
16. It has higher or similar efficacy to the previously-used whole cell pertussis vaccine, however the efficacy of the Acellular vaccine declines faster
17. The infant improved after treatment with clarithromycin and was administered the first dose of diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP).
18. Tetanus, diphtheria, Acellular pertussis vaccine (Tdap) Generic Name: tetanus, diphtheria, Acellular pertussis vaccine (Tdap) (TET a nus, dif THEER ee a, and ay SEL yoo ler per TUS iss) Brand Name: Adacel (Tdap), Boostrix (Tdap), Boostrix (obsolete2) (obsolete) Dosage Forms: intramuscular suspension (5 units-2 units-15.5 mcg/0.5 mL; 5 units-2.5 units-18.5 mcg/0.5 mL)
19. Immunization coverage Recommendation 3 Achieve and maintain age-appropriate immunization coverage with acellular pertussis vaccine in 95% of infants by 3 months of age (first dose) by 2010.
20. The challenge associated with vaccinating pregnant women is that the safety of acellular pertussis vaccine in pregnancy is unknown, as is the duration of protection and the effect of women’s
21. There are two formulations of acellular pertussis vaccine, the infant/pediatric formulation (aP) and the adolescent/adult formulation (ap). The latter contains a lower concentration of pertussis antigens than the former.
22. Similarly, all provinces have adopted a new acellular pertussis vaccine, known to be safer and potentially more effective than the whole-cell preparation in the shots that children had been receiving previously.
23. The safety of immunizing with tetanus-diphtheria-Acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak
24. During the discussion period, several provincial epidemiologists stated a preference for switching when a suitable five-antigen acellular pertussis vaccine becomes available, avoiding the confusion of step-wise changes and the need for extra injections.
25. Still, said Dr. Scheifele, acellular pertussis vaccine offers many advantages in terms of safety, immunogenicity and effectiveness in comparison with whole-cell vaccine, and the prospect of a "reconstructed" PENTA is not unrealistic if the Hib problem can be overcome.
26. ‘Seven Acellular gels were prepared as described above, but allowed to set for 30 min (to achieve stronger attachment to the plastic bars necessary for mechanical testing).’ ‘In 1996, the NVIC realized a major goal when the FDA licensed an improved pertussis vaccine known as the Acellular …
27. ‘Seven Acellular gels were prepared as described above, but allowed to set for 30 min (to achieve stronger attachment to the plastic bars necessary for mechanical testing).’ ‘In 1996, the NVIC realized a major goal when the FDA licensed an improved pertussis vaccine known as the Acellular …
28. At # to # months of age, PROCOMVAX may be given simultaneously with Merck MMR (Measles, Mumps, and Rubella Virus Vaccine Live), or OPV or with a booster dose of diphtheria, tetanus, acellular pertussis vaccine (DTaP) at # months of age in children who received the primary series of DTP
29. The principal safety study was a randomized, observer-blind, active controlled trial that enrolled participants 11-17 years of age (Adacel (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine Adsorbed) vaccine N = 1,184; Td vaccine N = 792) and 18-64 years of age (Adacel (tetanus toxoid, reduced diphtheria toxoid and
30. In a comparison of a four-component acellular pertussis vaccine and a whole cell vaccine given at 3, 4.5, 6 and 18 months of age in German trials(23), overall cough rates were similar in both groups, and the calculated efficacy over 6 years of follow-up was 89% for the acellular vaccine and 92% for the whole cell vaccine.